How to Improve Motivation & Overcome Procrastination | Dr. Masud Husain
Episode of Huberman Lab · August 24, 2026 · 2 h 21 min
Andrew Huberman and Oxford neurologist Masud Husain discuss the neuroscience of motivation, apathy, dopamine, effort-reward decisions, attention, ADHD, and Alzheimer's resilience.
Summary
Andrew Huberman interviewed neurologist Masud Husain about the biology of motivation and apathy. Husain described a patient, David, who became profoundly apathetic after two small strokes in the basal ganglia yet remained happy, and who recovered after treatment with the dopamine agonist ropinirole when levodopa had failed. Husain framed motivation as a neuroeconomic weighing of reward against effort, reporting that apathetic people and apathetic Oxford students decline low-reward options and, paradoxically, show greater brain activity when deciding, which he interpreted as a higher 'activation energy' barrier.
Husain recommended practical tools such as increasing or reframing incentives, subdividing tasks, and planning a day or week in advance to reduce repeated decision costs. The two discussed perseverance, reinforcement learning, the distinction between depression and apathy, ambition and happiness, the malleability of the self, and Husain's 'deathbed decision' approach to choosing work. Husain argued that addictive drugs hijack the same dopamine circuitry, that evidence for 'dopamine hits' from scrolling is weak, and that dopamine mediates wanting rather than liking.
Later segments covered internal versus external attention, working memory limits, the inverse U-shaped effect of stimulants, ADHD diagnosis and possible overdiagnosis, and limited evidence that attention training generalizes; Husain instead advised removing distractions. On Alzheimer's disease, Husain noted that many people with plaques and tangles never develop dementia, linked social connection, curiosity and purpose to cognitive resilience, and said apathy in healthy older adults doubles Alzheimer's risk. He expressed optimism about treatments including multiple sclerosis therapies, deep brain stimulation, and focused ultrasound drug delivery.
Chapters
- 0:46
Introduction
Huberman introduces Masud Husain, his work on motivation and apathy, and his book.
- 3:05
The case of David and pathological apathy
Husain recounts a patient who lost all motivation after basal ganglia strokes and recovered with a dopamine agonist.
- 15:43
Types of apathy and effort-reward decisions
Husain describes behavioral, social, emotional, and cognitive apathy and a neuroeconomic model of prioritizing goals.
- 23:25
Activation energy and the Oxford student study
Brain imaging showed apathetic students expend more brain activity deciding whether effort is worth reward.
- 29:24
Tools to increase motivation
The pair discuss changing incentives, subdividing tasks, planning ahead, and subjective perception of effort.
- 39:07
Learning, perseverance, depression and passion
Husain explains reinforcement learning, the need to persevere, and how depression differs from apathy.
- 50:58
Ambition, satisfaction and the changeable self
They discuss ambition and happiness, psychedelics, and how personal and social identity can change, including dementia risk factors.
- 1:11:34
Addiction, dopamine and social media
Husain argues drugs hijack motivation circuitry and that evidence for scrolling 'dopamine hits' is weak, distinguishing wanting from liking.
- 1:19:48
Dopamine, Parkinson's disease and executive function
Husain reframes Parkinson's slowing as reduced motivation to act and notes dopamine's roles in working memory and control.
- 1:26:43
Purpose, culture and deathbed decisions
They reflect on life's purpose, cultural transmission, and Husain's approach to choosing worthwhile work.
Linked moment · 1:33:23Skip to 1:33:23 using a listen link in the info box.
1:33:23Attention, working memory and stimulants
Husain explains attention as selection under limited capacity, working memory costs, and the inverse U-shaped stimulant curve.
- 1:48:53
ADHD and long-term goals
Husain discusses ADHD diagnosis, vigilance decrement, and the neuroscience of perseverance and temporal discounting.
- 1:59:42
Alzheimer's resilience and emerging treatments
Husain explains that Alzheimer pathology does not always cause dementia and describes advances in neurology.
- 2:10:59
Attention training, distraction and enrichment
Husain advises cutting distractions rather than training attention and shares his love of drawing.
Key points
What was said, by whom, with the exact words. Timestamps jump to the moment.
- Masud Husain
Husain says that motivated and apathetic people both work for high rewards, but apathetic people differ in declining low-reward options.
“We find that everyone is willing to work for high rewards. But the difference between motivated people and apathetic people is at the level of the low rewards”
- Masud Husain
Husain recounts that his patient David's apathy, caused by tiny basal ganglia strokes, was reversed after three months on ropinirole when levodopa had failed.
“three months after we started this medication, he came back. David came back to see us. And I did not recognize this guy in the waiting room”
- Masud Husain
Husain reports that apathetic students showed greater activity in reward-effort regions, indicating they expend more brain energy to make the same decision.
“It's showing us that apathetic people use more brain energy when they're making this decision. They have a bigger activation energy barrier to overcome”
- Masud Husain
Husain advises breaking large projects into smaller tasks to lower the activation energy required to start.
“What if you could break it down into smaller tasks which bring down that mountain, the activation energy required to get that small thing done?”
- Masud Husain
Husain recommends planning one's day or week in advance because every on-the-fly decision carries a brain energy cost.
“Every decision has a cost in terms, as we've seen, the brain having to put in, invest fuel to make that decision”
- Andrew Huberman
Huberman argues that people find their passion by becoming good at effort in things they are not passionate about.
“you find your passion by getting good at effort in things that you're not passionate about so that when you eventually find your passion, you can just get there much faster”
- Masud Husain
Husain says apathy and depression are separable, with some people showing pure apathy, others pure depression, and some both.
“there are some people who have pure apathy, no depression, like David, and there are other people who can be depressed, they can be sad, they can be hopeless about the future”
- Masud Husain
Husain cites evidence that maintaining social relationships and curiosity substantially lowers dementia risk.
“people who keep relationships, increase or maintain the number of social relationships they have, they have a far less risk of developing dementia than those who don't”
- Masud Husain
Husain argues that the same dopamine circuitry is hypoactive in apathy and hijacked into hyperactivity by addictive drugs.
“there's absolute convergence between this circuitry on the one hand being hypoactive and leading to apathy, on the other hand being hyperactive and leading to addictive states”
- Masud Husain
Husain says evidence that doom scrolling produces dopamine hits is not strong.
“I think the evidence that there are dopamine hits when you're doing this isn't really very strong”
- Masud Husain
Husain explains that dopamine modulates wanting, while liking or hedonic pleasure appears linked to opioid neurotransmitters.
“wanting, pursuit of a goal is mediated or modulated at least by dopamine, whereas actually the liking, the pleasure you might get from an outcome is not”
- Masud Husain
Husain reports that in Parkinson's patients, both reward incentives and added dopamine increase eye-movement velocity, supporting a motivation-to-act account.
“if you add dopamine to a patient with Parkinson's disease, that velocity increases even further. You've increased the vigor of a simple thing like an eye movement”
- Masud Husain
Husain warns high-performing students that stimulants may worsen rather than improve their performance due to the inverse U-shaped dopamine curve.
“So just think twice about taking some stimulant that you want to get a better grade, because actually the evidence would be that you might get worse from doing it”
- Masud Husain
Husain believes ADHD is real for some people but compatible with overdiagnosis, given variable testing and subjective thresholds.
“I think it is a real issue for some people. Interestingly, the number of people who remain with the diagnosis of ADHD into adulthood, if they had it as children, can reduce”
Listen from 1:49:56 · Attention deficit hyperactivity disorder
- Masud Husain
Husain notes that perhaps 20 to 30 percent of people who never had dementia show Alzheimer pathology at post-mortem.
“perhaps 20% to 30% of these individuals who never had dementia have Alzheimer pathology”
- Masud Husain
Husain says healthy older adults who score high for apathy have twice the risk of developing Alzheimer's disease.
“if they score highly for apathy, they have twice the risk of developing Alzheimer's disease than people who don't”
- Masud Husain
Husain says multiple sclerosis treatment has been transformed from only corticosteroids to a wide range of immune therapies.
“Now, there are a huge range of immune therapies for multiple sclerosis, which has transformed the lives of people with that diagnosis and the disability in that condition”
- Masud Husain
Husain says attention training benefits tend to be task-specific and recommends cutting distractions such as notifications instead.
“what you could do is to cut out things that are distracting for you. These are simple things that people will be very familiar with. Make sure you don't get notifications”
People
In the conversation
- Andrew HubermanAmerican neuroscientist, professor at Stanford School of Medicine and host of the Huberman Lab podcast
- Masud HusainProfessor of Neurology and Cognitive Neuroscience at the University of Oxford, expert on motivation and apathy, author of Our Brains, Our Selves
Discussed
- Oliver SacksNeurologist and author of Awakenings, cited regarding levodopa
- Marvin MinskyAI pioneer whose 'society of mind' concept Husain cited
- Carly SimonSinger who spoke about apathy after developing Parkinson's disease
- Kent BerridgeNeuroscientist known for research distinguishing wanting from liking
- Patricia Goldman-RakicNeuroscientist whose work linked dopamine to working memory
- Karl DeisserothStanford psychiatrist and co-developer of optogenetics
- Ethan CrossUniversity of Michigan psychologist and author of a book on inner chatter
- Ken RideoutEndurance athlete cited by Huberman for psychological race tactics
- Sanjay ManoharHusain's colleague on Parkinson's eye-movement studies
Topics
More from Huberman Lab
Best Tools for Gut Health & Weight Loss | Dr. Chris ThompsonSep 21, 2026 · 2 h 28 min
Andrew Huberman and gastroenterologist Chris Thompson discuss gut anatomy, fiber and the microbiome, GLP-1 drugs, early metabolic testing, gut permeability, and endoscopic and gene-therapy obesity treatments.
The Art of True Happiness | Dr. Arthur BrooksSep 14, 2026 · 2 h 50 min
Andrew Huberman and Arthur Brooks discuss the three macronutrients of happiness, the four worldly idols, leisure, addiction, faith, and questions for finding meaning.
How Mitochondria Control Your Metabolism | Dr. Jared RutterSep 7, 2026 · 2 h 4 min
Biochemist Jared Rutter explains to Andrew Huberman how mitochondria allocate cellular resources between energy and growth, shaping aging, heart failure, and cancer.
Using AI to Increase Your Intelligence & Enrich Humanity | Dr. Fei-Fei LiAug 10, 2026 · 2 h 8 min
Andrew Huberman and computer scientist Fei-Fei Li discuss vision, how modern AI learns, its limits versus human cognition, AI in medicine and robotics, and education.
Your Top Health Questions AnsweredJul 27, 2026 · 1 h 44 min
Andrew Huberman answers listener questions on late-night workouts, light exposure, memory, smell, fertility, menopause, surgery recovery and finding a passion.
From the publisher
Dr. Masud Husain is a Professor of Neurology & Cognitive Neuroscience at the University of Oxford and a leading expert on the science of motivation, apathy, and neurological diseases. We discuss how dopamine and specific brain circuits shape motivation, including how the brain weighs the trade-off between effort vs reward when deciding what goals to pursue. Dr. Husain also explains practical tools to increase motivation, reduce distractions, and make it easier to start and maintain goal pursuit. We also discuss dementia, Parkinson’s and Alzheimer’s disease, including new insights into cognitive resilience and factors that help protect against age-related cognitive decline. Show notes: https://go.hubermanlab.com/masud-husain-295 Thank you to our sponsors AG1: https://drinkag1.com/huberman David: https://davidprotein.com/huberman BetterHelp: https://betterhelp.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Masud Husain (00:02:24) Apathy, Motivation (00:08:07) Rewards, Apathy & Motivation; Dopamine (00:13:20) Sponsors: David & BetterHelp (00:15:44) Types of Apathy; Goal Prioritization: Effort vs Rewards (00:23:26) Motivation, Apathy, Tool: Activation Energy & Overthinking (00:29:24) Tools to Increase Motivation: Incentives, Subdivide Tasks, Planning (00:35:13) Subjective Effort, Mental Framing; Learning & Motivation (00:42:24) Sponsors: AG1 & Eight Sleep (00:44:54) Perseverance, Failure; Finding Your Passion, Depression vs Apathy (00:50:58) Self-Concept, Ambition; Life Satisfaction (00:58:25) Psychedelics, Anhedonia & Changing Self (01:03:09) Personal & Social Identity, Tools: Curiosity, Purpose & Dementia Risk (01:11:58) Addiction, Dopamine; Social Media & Dopamine "Hits"? (01:18:36) Sponsor: Function (01:20:13) Dopamine, Parkinson's Disease; Other Roles of Dopamine (01:26:59) Life Purpose, Culture; Reflection, Weighing Decisions (01:34:21) Internal & External Attention (01:39:59) Internal…
Summary, chapters and key points were generated from the episode transcript on October 4, 2026. Quotes are checked word for word against the transcript.